STOCK TITAN

ASLAN Pharmaceuticals to Present at the Annual Needham Virtual Healthcare Conference 2022

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary

ASLAN Pharmaceuticals (Nasdaq:ASLN) announced that CEO Dr. Carl Firth will present at the 21st Annual Needham Virtual Healthcare Conference. This event will take place from April 11 to 14, 2022, with Dr. Firth's presentation scheduled for April 14, 2022, from 10:15 to 10:55 AM ET. The presentation will be available for live listening and replay through the company's investor relations website. ASLAN is focused on developing innovative immunology treatments, including eblasakimab for atopic dermatitis and farudodstat for autoimmune diseases.

Positive
  • None.
Negative
  • None.

MENLO PARK, Calif. and SINGAPORE, April 06, 2022 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals (Nasdaq:ASLN), a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients, today announced that Dr Carl Firth, CEO, will present at the 21st Annual Needham Virtual Healthcare Conference. The conference will be held virtually from April 11 to 14, 2022.

Presentation details

Date: Thursday, April 14, 2022
Time: 10:15 - 10:55am ET
Format: Company presentation
Track: 2

Click here to listen-in live or via replay. This link will also be posted in the News & Events section of ASLAN Pharmaceutical’s Investor Relations website at https://ir.aslanpharma.com/.

Ends

Media and IR contacts

Emma Thompson
Spurwing Communications
Tel: +65 6206 7350
Email: ASLAN@spurwingcomms.com
Ashley R. Robinson
LifeSci Advisors, LLC
Tel: +1 (617) 430-7577
Email: arr@lifesciadvisors.com

About ASLAN Pharmaceuticals
ASLAN Pharmaceuticals (Nasdaq:ASLN) is a clinical-stage, immunology-focused biopharmaceutical company developing innovative treatments to transform the lives of patients. ASLAN is currently evaluating eblasakimab, a potential first-in-class antibody targeting the IL-13 receptor, in atopic dermatitis, and farudodstat (also known as ASLAN003), a potent oral inhibitor of the enzyme, DHODH, in autoimmune disease. ASLAN has a team in Menlo Park, California, and in Singapore. For additional information please visit www.aslanpharma.com or follow ASLAN on LinkedIn.


FAQ

When will ASLAN Pharmaceuticals present at the Needham Virtual Healthcare Conference?

ASLAN Pharmaceuticals will present on April 14, 2022, from 10:15 to 10:55 AM ET.

What is ASLN's focus in biopharmaceuticals?

ASLN focuses on developing innovative treatments in immunology, including therapies for atopic dermatitis and autoimmune diseases.

Who is presenting for ASLAN Pharmaceuticals at the conference?

Dr. Carl Firth, the CEO of ASLAN Pharmaceuticals, will present at the conference.

How can I listen to ASLAN Pharmaceuticals' presentation?

You can listen live or via replay on the ASLAN Pharmaceuticals investor relations website.

What drugs is ASLAN Pharmaceuticals currently developing?

ASLAN is developing eblasakimab for atopic dermatitis and farudodstat for autoimmune diseases.

ASLAN Pharmaceuticals Limited American Depositary Shares

NASDAQ:ASLN

ASLN Rankings

ASLN Latest News

ASLN Stock Data

1.70M
2.82M
0.14%
13.21%
1.35%
Biotechnology
Healthcare
Link
United States of America
Singapore